Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Moodys
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Bacitracin-neomycin-polymyxin W/ Hydrocortisone Acetate patents expire, and when can generic versions of Bacitracin-neomycin-polymyxin W/ Hydrocortisone Acetate launch?

Bacitracin-neomycin-polymyxin W/ Hydrocortisone Acetate is a drug marketed by Altana and Perrigo Co Tennessee and is included in two NDAs.

The generic ingredient in BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.

Summary for BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
Drug patent expirations by year for BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
Pharmacology for BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE

US Patents and Regulatory Information for BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Altana BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060731-002 Approved Prior to Jan 1, 1982 DISCN No No   See Pricing   See Pricing   See Pricing
Perrigo Co Tennessee BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062166-002 Approved Prior to Jan 1, 1982 RX No Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
McKinsey
Dow
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.